Creating an AI-ready data foundation for successful AI-enabled drug discovery
Over the past year, we have looked at drug discovery and development from several different...
BioStrand Omics Analysis Blog:
Drug Development
Computational biology and drug discovery: what to expect in 2023
The year 2022 in computational biology was largely marked by two main advancements:
Our most widely read blogs from 2022
It’s been another momentous year for the global life sciences industry. Ever since the pandemic...
Notes from BioTechX 2022
I recently had the privilege of representing the BioStrand Team at BioTechX, Europe’s largest...
Precision drugs for the precision medicine era
Currently, chemotherapy, using cytotoxic small molecules to kill cancer cells, is the predominant...
Explained: how to plot the prediction quality metrics with AlphaFold2
In a previous blog post, we discussed the importance of AlphaFold2 (as well as other, deep-learning...
A brief retrospective on our second blogiversary
It’s been an eventful two years, to the month, since we launched our omics and analysis blog. Our...
AI in Biopharma: Challenges and Opportunities
There are an estimated novemdecillion, or 1060, molecules in the known universe with potential...
Accelerate Biomarker Discovery with Artificial Intelligence
Biomarkers play a critical role in realizing the true potential of precision medicine. As accurate...
Top 4 challenges of equitable precision medicine
In our previous articles on precision medicine, we reviewed how advances in precision medicine...
Closing the Gap of Text and the Biosphere with LENSai™ NLP Link
Bridging the gap between raw sequence data, secondary research, experimental data, and the...